Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called Enhanced ALPP CAR-T cells for people with advanced solid tumors that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target a protein called ALPP found on some tumor cells. The…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New CAR-T therapy targets tough lung cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called TC-D101 for people with a specific type of advanced small cell lung cancer that has not responded to standard therapies. The treatment uses specially engineered immune cells (CAR-T cells) to target a protein called DLL3 on cance…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC